The HCPLive hospital medicine page is a comprehensive resource for clinical news and insights on the emergency medicine specialty. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for emergent care, and more.
February 9th 2025
Use of medications for secondary CVD prevention is low globally, and in most country income-level groups, with no indication of improvement.
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies
View More
Michael Aziz, MD: Abortion Reduces Risk of Death
June 24th 2022Abortion is much safer than having a term delivery and actually reduces the patient's chance of death–from a purely scientific perspective, which Aziz said, is the perspective all physicians should hold when they approach difficult situations.
When Cataract Surgeries Resumed in 2020, Complications Decreased
June 21st 2022Investigators presented the study at the Netherlands Ophthalmological Society Annual Congress, noting a potential cause for this trend could be the heightened cautiousness of surgical teams following the 2 month intermission due to the COVID-19 pandemic.
Study Provides Novel Insight on OUD Diagnosis Factors in Opioid-Naive Patients
May 19th 2022Presence of chronic liver disease, prior use of gabapentin and being discharged to a long-term hospital or rehabilitation center are among some of the factors associated with a new opioid use disorder diagnosis.
Phase 3 Data Show Isatuximab Offers Progression Free Survival for Multiple Myeloma
May 17th 2022Isatuximab in combination with carfilzomib and dexamethasone (Kd) demonstrate the longest median progression free survival (mPFS) on a proteasome inhibitor backbone in multiple myeloma patients who relapsed after a prior therapy, including lenalidomide.